PubMed HealthSearch

Biomedical subjects

D Meeker

Publications and source records attributed to D Meeker.

4 recordsLinked to original sources

The effect of prostaglandin E2 (PGE2) on amino acid uptake and protein formation by lung fibroblasts.

The effect of prostaglandin E2 (PGE2) on the utilization of extracellular amino acids by fetal lung fibroblasts was examined. PGE2 decreased the uptake of proline and aminoisobutyric acid (AIB) by quiescent fibroblasts in culture. The uptake of AIB by serum-activated cultures was also dramatically decreased by PGE2. The PGE2-induced decrease in the uptake of AIB was first observed at 4 h following the addition of the effector molecule to the cultures. PGE2 did not affect the uptake of leucine. The addition of cycloheximide also resulted in a decrease in the uptake of proline, similar to that induced by PGE2 at 5 X 10(-8) M. The combination of cycloheximide and PGE2 resulted in a further decrease in proline uptake. Kinetic analysis of AIB uptake following a 24-h PGE2 treatment showed an increase in the apparent Km as compared with untreated cultures. The prostaglandin remained active for at least 72 h after the addition of the molecule. Removal of the PGE2 was followed by an influx of proline into the cells. The decrease in proline uptake was associated with a decrease in the amount of intracellular free proline and an overall decrease in the amount of cell-associated protein. While PGE2 is known to increase intracellular protein degradation, the effect of PGE2 on amino acid uptake was not the result of an increase in the intracellular concentration of amino acids (transinhibition).

Amino Acids

Cleft palate and multiple anomalies in one of two siblings with partial 13 trisomy.

Siblings with multiple congenital anomalies secondary to familial partial trisomy of chromosome number 13 are described. In addition to other findings, the younger child exhibited a cleft of the soft palate. The mechanism of transmission of the chromosomal abnormalities, the relationship of the physical abnormalities and the chromosome findings, and the significance of these findings in the consideration of recurrence risks in future pregnancies are discussed.

Abnormalities, Multiple